Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 219-226

  Kim, Desok ^a   Gregory, Christopher W ^b   French, Frank S ^a,b   Smith, Gary J ^a,b   Mohler, James L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; KI 67 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CASTRATION; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 0036141411     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64365-9     Document Type: Article

References (51)

1. Androgen receptor defects: Historical, clinical, and molecular perspectives
2. Regulation of androgen action
3. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
4. Expression of early growth response genes in human prostate cancer
5. Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement
6. Activation of programmed cell death in the rat ventral prostate after castration
7. Androgen receptor status of lymph node metastases from prostate cancer
8. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer
9. Human androgen receptor expression in prostate cancer following androgen abiation
10. Xenografts of primary human prostatic carcinoma
11. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma
12. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
13. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
14. Androgen, receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft
15. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen independent prostate cancer xenograft model CWR22-R
16. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy
17. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis
18. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy
19. Heterogeneity of androgen receptor content in advanced prostate cancer
20. Immunohistochemical quantitation of androgen receptor expression using, color video image analysis
21. Application of avidin-biotin complex technique for the localization of estradiol receptor in target tissues using monoclonal antibodies
22. Immunocytochemistry is automated: Development of a robotic workstation based upon the capillary action principle
23. Epitope prediction and confirmation for the human androgen receptor: Generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy
24. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody K1-67
25. Characterization of the gene for prostate-specific antigen: A human glandular kallikrein
26. Immunohistochemical localization of the androgen receptor in rat and human tissues
27. Autoregulation of androgen receptor expression in rodent prostate: Immunohistochemical and in situ hybridization analysis
28. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
29. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor
30. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains
31. Androgen-dependent protein interactions within an intron-1 regulatory region of the 20-kDa protein gene
32. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability
33. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
34. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen
35. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP
36. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen, promoter
37. Vitamin D and prostate cancer: 1,25 Dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines
38. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors
39. Androgen receptor gene and hormonal therapy failure of prostate cancer
40. Mechanism of androgen receptor activation and possible implications for chemoprevention trials
41. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase: A signal transduction pathway
42. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
43. Synergism between androgens and protein kinase C on androgen-regulated gene expression
44. Activation of the human androgen receptor through a protein kinase A signaling pathway
45. Synergistic activation of androgen receptor by androgen and leutinizing hormone-releasing hormone in prostatic carcinoma cells
46. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway
47. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein
48. Prostate cancer: Molecular biology of early progression to androgen independence
49. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor and epidermal growth factor
50. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signalling by the HER-2/neu tyrosine kinase
51. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy